{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:45:42Z","timestamp":1774352742596,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.msard.2022.103662","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T12:00:26Z","timestamp":1643976026000},"page":"103662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis"],"prefix":"10.1016","volume":"59","author":[{"given":"Meltem Y\u0131ld\u0131z","family":"Kayao\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6zde","family":"Girgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7943-9611","authenticated-orcid":false,"given":"Ismail","family":"Solmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terken","family":"Baydar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Banu","family":"Anlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.msard.2022.103662_bib0037","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2169\/internalmedicine.54.3660","article-title":"Human T-lymphotropic virus type-I (HTLV-I)-associated myelopathy with bulbar palsy-type amyotrophic lateral sclerosis-like symptoms","volume":"54","author":"Ando","year":"2015","journal-title":"Intern. Med."},{"issue":"5","key":"10.1016\/j.msard.2022.103662_bib0032","doi-asserted-by":"crossref","first-page":"s301","DOI":"10.1007\/s10072-003-0180-5","article-title":"Beta-2 microglobulin and neopterin as markers of disease activity in multiple sclerosis","volume":"24","author":"Bagnato","year":"2003","journal-title":"Neurolog. Sci."},{"issue":"6","key":"10.1016\/j.msard.2022.103662_bib0043","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00128-012-0845-y","article-title":"Evaluation of tetrahydrobiopterin pathway in operating room workers: changes in biopterin status and tryptophan metabolism","volume":"89","author":"Baydar","year":"2012","journal-title":"Bull. Environ. Contam. Toxicol."},{"issue":"1","key":"10.1016\/j.msard.2022.103662_bib0024","doi-asserted-by":"crossref","first-page":"e20160120","DOI":"10.1542\/peds.2016-0120","article-title":"Characteristics of children and adolescents with multiple sclerosis","volume":"138","author":"Belman","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.msard.2022.103662_bib0030","doi-asserted-by":"crossref","first-page":"s265","DOI":"10.1007\/s10072-003-0170-7","article-title":"Inflammation and degeneration in multiple sclerosis","volume":"24","author":"Br\u00fcck","year":"2003","journal-title":"Neurolog. Sci."},{"issue":"6","key":"10.1016\/j.msard.2022.103662_bib0011","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/MOP.0b013e3283402b71","article-title":"Biomarkers of inflammatory and auto-immune central nervous system disorders","volume":"22","author":"Dale","year":"2010","journal-title":"Curr. Opin. Pediatr."},{"issue":"4","key":"10.1016\/j.msard.2022.103662_bib0014","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1469-8749.2008.03225.x","article-title":"Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation","volume":"51","author":"Dale","year":"2009","journal-title":"Dev. Med. Child Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.103662_bib0034","first-page":"321","article-title":"Cerebrospinal fluid and urinary biomarkers in multiple sclerosis","volume":"128","author":"Dobson","year":"2013","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0042","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.msard.2012.01.002","article-title":"Urine: an under-studied source of biomarkers in multiple sclerosis?","volume":"1","author":"Dobson","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103662_bib0038","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1479-5876-9-42","article-title":"Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients","volume":"9","author":"Durastanti","year":"2011","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.msard.2022.103662_bib0022","first-page":"76","article-title":"Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis","volume":"67","author":"Fredrikson","year":"1987","journal-title":"Clin. Exp. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.msard.2022.103662_bib0013","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3109\/10408369209114604","article-title":"The role of neopterin as a monitor of cellular immune activation in transplantation, inflammatory, infectious, and malignant diseases","volume":"29","author":"Fuchs","year":"1992","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.msard.2022.103662_bib0012","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jpsychires.2015.10.003","article-title":"Neopterin as a potential cytoprotective brain molecule","volume":"71","author":"Ghisoni","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.msard.2022.103662_bib0008","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/135245859800400330","article-title":"Urinary markers of disease activity in multiple sclerosis","volume":"4","author":"Giovannoni","year":"1998","journal-title":"Multi. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2022.103662_bib0033","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/brain\/120.1.1","article-title":"Daily urinary neopterin excretion as an immunological marker of disease activity in multiple sclerosis","volume":"120","author":"Giovannoni","year":"1997","journal-title":"Brain J. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103662_bib0021","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/15376516.2010.545960","article-title":"Tryptophan degradation and serum neopterin concentrations in intensive care unit patients","volume":"21","author":"Girgin","year":"2011","journal-title":"Toxicol. Mech. Methods"},{"issue":"1","key":"10.1016\/j.msard.2022.103662_bib0031","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1515\/pteridines.2012.23.1.90","article-title":"Evaluation of serum and urinary levels of some pteridine pathway components in healthy Turkish children","volume":"23","author":"Girgin","year":"2012","journal-title":"Pteridines"},{"key":"10.1016\/j.msard.2022.103662_bib0017","series-title":"Diseases of the Brain","first-page":"2020","author":"Hodler","year":"2022"},{"issue":"6","key":"10.1016\/j.msard.2022.103662_bib0039","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/0091270011407068","article-title":"A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biology","volume":"52","author":"Hu","year":"2012","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.msard.2022.103662_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577088","article-title":"Elevated quinolinic acid levels in cerebrospinal fluid in subacute sclerosing panencephalitis","volume":"339","author":"Inoue","year":"2020","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.msard.2022.103662_bib0016","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International pediatric multiple sclerosis study group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103662_bib0009","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3389\/fimmu.2016.00246","article-title":"Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis","volume":"7","author":"Lovelace","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0004","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jpeds.2003.10.056","article-title":"First episode of acute CNS inflammatory demyelination in childhood: prognostic factors for multiple sclerosis and disability","volume":"144","author":"Mikaeloff","year":"2004","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0044","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2174\/1389200024605082","article-title":"Neopterin as a marker for immune system activation","volume":"3","author":"Murr","year":"2002","journal-title":"Curr. Drug Metab."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0006","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1542\/peds.110.2.e21","article-title":"Acute disseminated encephalomyelitis in children","volume":"110","author":"Murthy","year":"2002","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0002","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1177\/0883073812443006","article-title":"Masquerades of acquired demyelination in children: experiences of a national demyelinating disease program","volume":"28","author":"O'Mahony","year":"2013","journal-title":"J. Child Neurol."},{"issue":"8","key":"10.1016\/j.msard.2022.103662_bib0001","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","article-title":"The spectrum of MOG autoantibody-associated demyelinating diseases","volume":"9","author":"Reindl","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2022.103662_bib0035","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1177\/1352458510375100","article-title":"Urinary neopterin and nitric oxide metabolites as markers of interferon \u03b2-1a activity in primary progressive multiple sclerosis","volume":"16","author":"Rejdak","year":"2010","journal-title":"Mult. Scler. J."},{"issue":"9","key":"10.1016\/j.msard.2022.103662_bib0040","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1177\/1352458510375100","article-title":"Urinary neopterin and nitric oxide metabolites as markers of interferon beta-1a activity in primary progressive multiple sclerosis","volume":"16","author":"Rejdak","year":"2010","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2022.103662_bib0005","doi-asserted-by":"crossref","first-page":"s326","DOI":"10.1007\/s10072-004-0335-z","article-title":"Multiple sclerosis in children under 10 years of age","volume":"25","author":"Ruggieri","year":"2004","journal-title":"Neurolog. Sci."},{"issue":"4","key":"10.1016\/j.msard.2022.103662_bib0007","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/135245859900500416","article-title":"Biological markers in body fluids for activity and progression in multiple sclerosis","volume":"5","author":"S\u00f9rensen","year":"1999","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0019","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03345704","article-title":"Is neopterin level a predictive and differential biomarker in patients with thyroid disorders?","volume":"32","author":"Sahin","year":"2009","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"10.1016\/j.msard.2022.103662_bib0025","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.3390\/ijms19123796","article-title":"The persisting significance of oligoclonal bands in the dawning era of kappa free light chains for the diagnosis of multiple sclerosis","volume":"19","author":"Schwenkenbecher","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2022.103662_bib0036","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1373\/jalm.2019.030007","article-title":"High-throughput urinary neopterin-to-creatinine ratio monitoring of systemic inflammation","volume":"5","author":"Stuart","year":"2020","journal-title":"J. Appl. Lab. Med."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0003","first-page":"36","article-title":"Multiple sclerosis in children","volume":"11","author":"Tardieu","year":"2004","journal-title":"Int. MS J."},{"issue":"5","key":"10.1016\/j.msard.2022.103662_bib0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2174\/1389200217666151222155043","article-title":"Brain aging and disorders of the central nervous system: kynurenines and drug metabolism","volume":"17","author":"Toeroek","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.msard.2022.103662_bib0029","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3389\/fimmu.2020.00760","article-title":"B and T cells driving multiple sclerosis: identity, mechanisms and potential triggers","volume":"11","author":"Van Langelaar","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.msard.2022.103662_bib0010","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/neuonc\/nov092","article-title":"CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma","volume":"17","author":"Viaccoz","year":"2015","journal-title":"Neuro Oncol."},{"issue":"9 Supplement 2","key":"10.1016\/j.msard.2022.103662_bib0026","first-page":"S74","article-title":"Pediatric multiple sclerosis: clinical features and outcome","volume":"87","author":"Waldman","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.msard.2022.103662_bib0027","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/archneurol.2009.135","article-title":"Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults","volume":"66","author":"Waubant","year":"2009","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2022.103662_bib0020","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1093\/clinchem\/43.12.2424","article-title":"Simultaneous measurement of serum tryptophan and kynurenine by HPLC","volume":"43","author":"Widner","year":"1997","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.msard.2022.103662_bib0028","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1515\/pteridines.1998.9.2.91","article-title":"Indicator of oxidative stress and part of the cytotoxic armature of activated macrophages in humans","volume":"9","author":"Widner","year":"1998","journal-title":"Pteridines"},{"issue":"6","key":"10.1016\/j.msard.2022.103662_bib0023","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ejpn.2017.06.004","article-title":"Characteristics of pediatric multiple sclerosis: the Turkish pediatric multiple sclerosis database","volume":"21","author":"Y\u0131lmaz","year":"2017","journal-title":"Eur. J. Paediatr. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2022.103662_bib0018","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1515\/pteridines.2007.18.1.132","article-title":"Neopterin, catalase and superoxide dismutase in females with benign and malignant breast tumors","volume":"18","author":"Yuksel","year":"2007","journal-title":"Pteridines"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822001778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822001778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:58:40Z","timestamp":1761901120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822001778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":44,"alternative-id":["S2211034822001778"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103662","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103662","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103662"}}